ARTICLE
|
doi:10.20944/preprints202402.0541.v1
Subject:
Biology And Life Sciences,
Immunology And Microbiology
Keywords:
SARS-CoV-2; SARS-CoV-2 neutralizing antibodies; COVID-19; Pediatric Population; BNT162b2 (Pfizer-BioNTech); CoronaVac (Sinovac); Heterologous vaccination; Chile
Online: 9 February 2024 (09:16:59 CET)